Background

Schizophrenia is a complex mental disorder with a heritability of 70-80%, yet the molecular genetic factors determining its risk remain largely shrouded in mystery. To date, large-scale genome-wide association studies (GWAS) for mental disorders have been predominantly biased toward European populations. This population bias has limited the ability to precisely capture disease risk factors in non-European populations, acting as a barrier to implementing precision medicine that reflects ethnic differences in genetic structure.

Copy Number Variants (CNVs), which involve deletions or duplications of chromosomal segments, are considered high-risk rare variants that significantly impact the onset of schizophrenia. While existing Single Nucleotide Polymorphism (SNP)-based studies have mainly addressed the cumulative effects of common variants, CNVs—chromosomal structural changes ranging from several kilobases to several megabases—can decisively influence neurodevelopmental pathways through individual variants alone. However, because rare CNV research has also been focused primarily on Western populations, the systematic identification of risk variants unique to other populations, including East Asians, or common human risk genes has remained stagnant.

Key Findings

Researchers have newly identified rare CNVs closely associated with the onset of schizophrenia through a precise analysis of East Asian genomic data. By applying rigorous quality control and high-resolution analysis algorithms, they identified unique genomic structural variant regions appearing in the East Asian cohort. New genetic clues, which were not captured in Western-centric studies, emerged for the first time through the analysis of non-European populations.

Subsequently, the researchers undertook a large-scale meta-analysis combining East Asian data with existing European population data. By integrating multi-ethnic cohorts, additional risk gene loci, which were obscured due to a lack of statistical power in single-population studies, showed distinct association signals. This is the result of dramatically increasing analysis resolution by integrating genetic diversity across populations.

The new gene loci identified in the meta-analysis were concentrated in gene groups that exhibit intolerance to Loss-of-Function (LoF) mutations. This provides physical evidence that vulnerability to disease increases sharply when structural deletions or duplications occur in essential genes preserved throughout evolution because they cannot tolerate mutations. This clearly supports the premise that structural damage to core neural gene networks acts as a fundamental pathogenic mechanism, regardless of ethnic background.

Significance and Outlook

This research is evaluated as having expanded the horizon of genomic studies, which were previously focused on specific populations, to include non-European groups, thereby gaining deeper insights into the molecular mechanisms of neuropsychiatric disorders. It serves as a clear demonstration of the principle that statistical power for discovering rare variants and unknown risk loci is maximized when analysis samples are diversified by integrating inter-ethnic data. It offers the insight that completing the full pathway of complex brain diseases requires overcoming the inherent limitations of research focused on a single ethnicity and encompassing the genetic diversity of various ethnic groups.

The fact that the identified risk loci are clustered in LoF-intolerant genes will serve as a powerful compass for selecting future therapeutic targets. A foundation has been laid to model pathophysiology, centered on key gene networks involved in neural development and the maintenance of synaptic homeostasis, and to conduct targeted pharmacological research.

However, to elucidate the molecular mechanisms by which the newly identified rare CNVs affect cerebral cortical neuron differentiation and synaptic plasticity, extensive cell and animal functional studies must follow. The challenge remains of expanding genomic data to encompass more diverse ethnic cohorts and conducting parallel research linking these to precise clinical phenotypes.